Archive for June, 2002
Celera abandons gene sequencing
Celera abandons gene sequencing
The company that shared the glory for unravelling the code of life of human beings has turned its back on gene sequencing. Celera Genomics of Rockville, Maryland, announced this week that it is to develop drugs instead
Biotrends
Biotrends
Two major reports highlight the globalization of biotechnology and the battle within the U.S. for regional supremacy
Where the Biotech Bets Are
Where the Biotech Bets Are
John McCamant of The Medical Technology Stock Letter tells where he’s making his in this poorly performing sector.
Biotech lobbyists’ clout grows in Washington
Biotech lobbyists’ clout grows in Washington
The Biotechnology Industry Organization is still unpacking from its move into a bigger office a few blocks from the White House, underscoring the outfit’s rapid climb to lobbying juggernaut status.
Gene Doping Threatens to Transform Sports
Gene Doping Threatens to Transform Sports
“If it does take off, sport as we know it will disappear”
